Topic List : Immunology
Progress in peanut-allergy immunotherapy
As immunotherapy for peanut allergy advances, a Stanford allergy expert discusses what that means for parents, providers and the future of allergy treatments.
Farming linked to gut microbiome changes
Researchers at Stanford and several other institutions have linked the gut ecosystems of four Himalayan groups to the extent of each group’s departure from a hunter-gatherer lifestyle.
Safer gene therapy?
A new study gives Stanford researchers hope that they may have solved a big problem plaguing gene therapy: the prospect of an autoimmune attack.
Gut molecule protects against Salmonella
A molecule called propionate inhibits the growth of Salmonella in mice and may be a promising new treatment for people sickened by the pathogen, according to a new Stanford study.
Nicotine-mimicking molecules as medicine?
Stanford researchers discovered that a receptor that binds to nicotine and to clusters of beta-amyloid molecules is found on certain types of immune cells that can act as suppressors and regulators of the immune system.
Cellular ‘death code’ discovered
Stanford scientists and their collaborators have discovered a molecule that initiates the final, crucial step in a type of cell death.
Special diet helps bacteria engraft in gut
Gut bacteria able to digest seaweed can outcompete native bacteria in the large intestine of nori-fed mice, according to Stanford scientists. Favoring one species over others in the gut could help advance precision health.
$11.9 million for anti-leukemia trial
The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.
Older people’s immune cells diverge more
Stanford scientists, focusing on chemical adjuncts affixed to DNA-associated proteins, found that these markings become more diverse with age.
Altered immune cells attack brain tumor
In mice, a fatal brainstem tumor was cleared by injecting it with engineered T cells that recognized the cancer and targeted it for destruction. The Stanford discovery is moving to human trials.